A detailed history of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys transactions in Abb Vie Inc. stock. As of the latest transaction made, Commonwealth Of Pennsylvania Public School Empls Retrmt Sys holds 384,516 shares of ABBV stock, worth $66 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
384,516
Previous 387,875 0.87%
Holding current value
$66 Million
Previous $66.5 Million 14.14%
% of portfolio
0.49%
Previous 0.45%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$163.84 - $199.33 $550,338 - $669,549
-3,359 Reduced 0.87%
384,516 $75.9 Million
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $44,579 - $52,058
288 Added 0.07%
387,875 $66.5 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $152,947 - $174,269
957 Added 0.25%
387,587 $70.6 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $4.37 Million - $4.92 Million
31,736 Added 8.94%
386,630 $59.9 Million
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $6.3 Million - $7.3 Million
47,196 Added 15.34%
354,894 $52.9 Million
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $1.05 Million - $1.3 Million
7,897 Added 2.63%
307,698 $41.5 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $125,376 - $144,390
867 Added 0.29%
299,801 $47.8 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $5.58 Million - $6.69 Million
40,316 Added 15.59%
298,934 $48.3 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $178,096 - $204,265
1,327 Added 0.52%
258,618 $34.7 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $2.85 Million - $3.63 Million
20,744 Added 8.77%
257,291 $39.4 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $1.93 Million - $2.4 Million
14,647 Added 6.6%
236,547 $38.3 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $47,591 - $60,216
443 Added 0.2%
221,900 $30 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $17,981 - $20,411
169 Added 0.08%
221,457 $23.9 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $45,661 - $50,869
434 Added 0.2%
221,288 $24.9 Million
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $26,086 - $28,718
255 Added 0.12%
220,854 $23.9 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $4.59 Million - $6.2 Million
57,079 Added 34.91%
220,599 $23.6 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $5.39 Million - $6.33 Million
62,747 Added 62.27%
163,520 $14.3 Million
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $5.88 Million - $7.87 Million
80,178 Added 389.31%
100,773 $9.89 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $2.31 Million - $3.5 Million
-35,752 Reduced 63.45%
20,595 $1.57 Million
Q4 2019

Feb 11, 2020

SELL
$72.13 - $90.25 $665,832 - $833,097
-9,231 Reduced 14.08%
56,347 $4.99 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $1.34 Million - $1.61 Million
-21,210 Reduced 24.44%
65,578 $4.97 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $36,200 - $46,272
551 Added 0.64%
86,788 $6.31 Million
Q1 2019

May 07, 2019

BUY
$77.14 - $90.79 $322,136 - $379,139
4,176 Added 5.09%
86,237 $6.95 Million
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $3.29 Million - $4.05 Million
-42,202 Reduced 33.96%
82,061 $7.57 Million
Q3 2018

Nov 08, 2018

SELL
$88.91 - $98.84 $3.06 Million - $3.4 Million
-34,380 Reduced 21.67%
124,263 $11.8 Million
Q2 2018

Aug 03, 2018

BUY
$89.78 - $106.23 $1.44 Million - $1.7 Million
16,001 Added 11.22%
158,643 $14.7 Million
Q1 2018

May 09, 2018

BUY
$92.01 - $123.21 $4,968 - $6,653
54 Added 0.04%
142,642 $13.5 Million
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $1.16 Million - $1.27 Million
12,945 Added 9.99%
142,588 $13.8 Million
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $9.06 Million - $11.6 Million
129,643
129,643 $11.5 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.